Diagenode - About the company
Diagenode is an acquired company based in Seraing (Belgium), founded in 2003. It operates as a Developer of portfolio of reagents and kits for epigenetics sequencing solutions. Diagenode has raised $8.45M in funding from investors like Capricorn Partners, SRIW and Ostbelgieninvest, with last known valuation of $*****. The company has 413 active competitors, including 48 funded and 71 that have exited. Its top competitors include companies like Illumina, Enzo and Arbor Biotechnologies.
Company Details
Diagenode develops epigenetics solutions and services for life science research. Its flagship product IP-Star Compact is an automated bench-top solution for high-throughput epigenetic sequencing. It has automated protocols for chromatin immunoprecipitation (ChIP), methylated DNA immunoprecipitation (MeDIP), hydroxymethylated DNA immunoprecipitation (hMeDIP), methyl-binding domain protein capture assays (MethylCap), sequential ChIP (Re-ChIP), bisulfite conversion and DNA immunoprecipitation (RNA-IP). In addition, the company provides epigenetic sequencing services, reagents, kits, bioinformatics software associated with IP-Star.
- Website
- diagenode.com/en
- Social
- Registered Address
- Rue du Bois St-Jean 3 4102 Seraing Since October 14, 2013
Key Metrics
Founded Year
2003
Location
Seraing, Belgium
Stage
Acquired
Total Funding
$8.45M in 12 rounds
Latest Funding Round
Last Known Valuation
$***** as on Mar 01, 2021
Investors
Ranked
38th among 413 active competitors
Annual Revenue
€10M - €50M as on Sep 30, 2025
Employee Count
123 as on Aug 31, 2026
Investment & Acquisitions
Exit Details
Acquired by Hologic (Mar 01, 2021)
Legal entities associated with Diagenode
Diagenode is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
DIAGENODE CIN: 0480.422.786 , Belgium, Active | May 29, 2003 | €10M - €50M (As on Sep 30, 2025) | 99 (As on Mar 31, 2020) | - |
Diagenode's acquisition details
Click here to take a look at Diagenode's acquisition in detail
Sign up to download Diagenode's company profile
Diagenode's funding and investors
Diagenode has raised a total funding of $8.45M over 12 rounds. Its first funding round was on Jun 01, 2014. Its latest funding round was a Grant (prize money) round on Sep 01, 2019 for $*****. 1 investor participated in its latest round. Diagenode has 7 institutional investors.
Here is the list of recent funding rounds of Diagenode:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 01, 2019 | 7159611 | Grant (prize money) | 9298183 | 6822960 | 3048589 | 4654464 |
Jul 01, 2019 | 1466750 | Grant (prize money) | 3206801 | 8745117 | 7719488 | |
Jun 01, 2019 | 6369860 | Grant (prize money) | 1768473 | 8185716 | 8973384 |
Access funding benchmarks and valuations. Sign up today!View details of Diagenode's funding rounds and investors
Diagenode's founders and board of directors
Founder? Claim ProfileDiagenode's employee count trend
Diagenode has 123 employees as of Aug 26. Here is Diagenode's employee count trend over the years:
Uncover Diagenode's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Diagenode's Competitors and alternates
Top competitors of Diagenode include Illumina, Enzo and Arbor Biotechnologies. Here is the list of Top 10 competitors of Diagenode, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Illumina 1993, San Diego (United States), Public | Developer of technologies for analysis of genetic variation and function | $28M | 71/100 | |
2nd | Enzo 1976, Farmingdale (United States), Acquired | Life science products and services for research, drug discovery, and manufacturing | $7M | - | 65/100 |
3rd | Arbor Biotechnologies 2016, Cambridge (United States), Series C | Provider of genomic technologies and drug discovery platform | $304M | 64/100 | |
4th | Provider of gene sequencing instruments, reagents, equipment, and related products | $1B | 63/100 | ||
5th | Sino Biological 2007, Beijing (China), Series A | Provider of reagents,and kits for clinical research | $29.4M | 63/100 | |
6th |  Eclipse Bio 2017, San Diego (United States), Series A | Developer of cell-free immunoassay | $18.9M | 61/100 | |
7th | Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders | $15.5M | 61/100 | ||
8th | Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised | Develops tools and products for research and clinical application | - | 58/100 | |
9th |  BioIVT 1981, Westbury (United States), Acquired | Provider of in vitro diagnostic products and assay services | - | 56/100 | |
10th | Teknova 1996, Hollister (United States), Public | Provider of molecular biology research reagents and kits | - | 56/100 | |
38th | Developer of portfolio of reagents and kits for epigenetics sequencing solutions | $8.45M | 45/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Diagenode's competitors? Click here to see the top ones
Diagenode's Investments and acquisitions
Diagenode has acquired NXT-Dx. Diagenode has not made any investments as of now.Reports related to Diagenode
Here is the latest report on Diagenode's sector:
News related to Diagenode
Filter this list•
•
Hologic Acquires European MDx Firm Diagenode for Approximately $159M360Dx•Mar 01, 2021•Hologic, Diagenode
•
•
•
•
•
•
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Diagenode
Explore our recently published companies
- Himsons - Vadodara based, 1988 founded, Unfunded company
- Com2uS Platform Corp - Unfunded company
- Just Print - Unfunded company
